Topical medication administration involves applying drugs directly to a body surface, such as the skin or mucous membranes, to achieve a localized or systemic therapeutic effect. In midwifery practice across Nigeria, this route is frequently utilized for managing perineal lacerations, treating fungal or bacterial skin infections in newborns, and soothing sore nipples during lactation. Unlike oral or intravenous routes that distribute drugs throughout the entire body via the bloodstream, topical treatments act primarily at the site of application. This localized action minimizes systemic side effects, making it particularly safe and effective for mothers and infants. Midwives must understand that the skin acts as a selective barrier, meaning the choice of formulation heavily influences how well a drug penetrates the tissues. Proper application ensures the medication reaches the target site effectively while maintaining skin integrity.
The skin consists of three main layers: the epidermis, the dermis, and the subcutaneous tissue. The outermost layer of the epidermis, the stratum corneum, is the primary barrier preventing drug penetration. Mucous membranes, found in the vaginal, oral, and nasal cavities, lack this tough outer horny layer and are richly supplied with blood vessels. Consequently, drugs applied to mucous membranes absorb much faster and more completely than those applied to intact skin. Skin hydration, temperature, and integrity also affect drug absorption. Broken or inflamed skin, such as an episiotomy site, absorbs topical agents at a significantly higher rate, increasing the risk of systemic toxicity if high-potency drugs are used.
Topical drugs come in various formulations, each suited for different clinical conditions in mothers and babies.
In obstetric and gynecological settings, topical medications serve multiple clinical purposes. They relieve local pain and inflammation associated with hemorrhoids, perineal tears, or vulvovaginal candidiasis. Antiseptic creams and solutions cleanse wounds and prevent hospital-acquired infections on surgical abdominal scars following a cesarean section. Barrier creams protect neonatal skin from diaper dermatitis by shielding the epidermis from moisture and stool enzymes. Furthermore, hormonal pessaries are sometimes prescribed to prepare the cervix or treat atrophic vaginitis. The overarching goal is always to maximize local therapeutic efficacy while minimizing systemic exposure and avoiding toxicity to delicate tissues.
Executing a topical application correctly prevents contamination and ensures even drug distribution. First, perform hand hygiene and put on clean gloves to protect yourself and the patient. Gently clean the target area with warm water or mild soap and pat it dry with a clean gauze pad, taking care not to rub fragile tissues. If using a jar of cream or ointment, use a clean tongue depressor or spatula to scoop out the required amount rather than dipping gloved fingers directly inside, which introduces bacteria. Apply a thin, even layer of the medication using smooth, gentle strokes following the direction of hair growth to prevent folliculitis. For dressings, apply a sterile cover only if ordered by the clinician.
Before applying any topical agent, the midwife must explain the procedure clearly to the mother, detailing what medication is being used, why it is needed, and what sensations to expect. Obtaining informed verbal consent builds trust and cooperation, especially when dealing with sensitive areas like the perineum or breasts. Assess the patient for any known allergies to the drug or base ingredients. Proper personal hygiene of the patient is mandatory; wash and dry the treatment site thoroughly to remove old medication residue, sweat, or discharge before applying a fresh dose. Privacy must be ensured using curtains or screens, as modesty is paramount during obstetric and gynecological procedures.
Although topical medications are generally safe, adverse reactions can still occur. Contact dermatitis, characterized by sudden redness, itching, burning, or a rash at the application site, is a common hypersensitivity response to either the active drug or preservatives like parabens. Over-application of potent corticosteroids can lead to skin thinning (atrophy), striae, and hypopigmentation. In neonates or patients with broken skin, excessive absorption can trigger systemic toxicity. If a mother exhibits signs of an allergic reaction or severe local irritation, the midwife must immediately stop the medication, gently wash the area with clean water, and report the incident to the supervising clinician.
Accurate documentation is a legal and professional responsibility in midwifery practice. Following every topical application, the midwife must record the date, time, exact drug name, concentration, site of application, and the patient's response in the clinical chart. If applying treatments to wounds or lacerations, note the appearance of the tissue, including any signs of healing or infection such as swelling or discharge. Post-application monitoring involves checking the patient after a reasonable interval to assess whether the therapeutic goal was met—such as pain relief or reduced inflammation—and to ensure no adverse skin reactions have developed.